Switch to:
Valeant Pharmaceuticals International Inc (NYSE:VRX)
EV/EBITDA
26.25 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Valeant Pharmaceuticals International Inc's enterprise value is $110,831 Mil. Valeant Pharmaceuticals International Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2015 was $4,222 Mil. Therefore, Valeant Pharmaceuticals International Inc's EV/EBITDA ratio for today is 26.25.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Valeant Pharmaceuticals International Inc's stock price is $224.05. Valeant Pharmaceuticals International Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2015 was $2.44. Therefore, Valeant Pharmaceuticals International Inc's P/E Ratio for today is 92.01.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Valeant Pharmaceuticals International Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=110831.477/4222.1
=26.25

Valeant Pharmaceuticals International Inc's current Enterprise Value is $110,831 Mil.
Valeant Pharmaceuticals International Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2015 was 1074.4 (Sep. 2014 ) + 1304.5 (Dec. 2014 ) + 860.2 (Mar. 2015 ) + 983 (Jun. 2015 ) = $4,222 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Valeant Pharmaceuticals International Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=224.05/2.435
=92.01

Valeant Pharmaceuticals International Inc's share price for today is $224.05.
Valeant Pharmaceuticals International Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2015 was 0.81 (Sep. 2014 ) + 1.565 (Dec. 2014 ) + 0.21 (Mar. 2015 ) + -0.15 (Jun. 2015 ) = $2.44.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Valeant Pharmaceuticals International Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda 8.76-22.534.896.066.64113.5523.0026.1336.9417.19

Valeant Pharmaceuticals International Inc Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
ev2ebitda 27.5026.2845.2536.9435.7228.1819.5917.1925.2426.49
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK